GO:0033280 response to vitamin D: Endocrine Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033280 (response to vitamin D) describes any cellular or organismal process that changes in state or activity in response to a vitamin D stimulus, including gene expression, secretion, and enzyme production.
• Vitamin D is obtained from diet or synthesized in skin and is converted to the active hormone 1,25-dihydroxyvitamin D, which regulates calcium and phosphate homeostasis and immune function.
• The response to vitamin D is mediated primarily by the vitamin D receptor (VDR), a nuclear receptor that heterodimerizes with RXR and binds vitamin D response elements (VDREs) to modulate transcription.
• Vitamin D supplementation can reduce the risk of acute respiratory infections, particularly in individuals with severe deficiency.
• Both vitamin D2 and vitamin D3 can raise serum 25-hydroxyvitamin D, but D3 is generally more effective at sustaining circulating levels.
• Studying response to vitamin D requires integrated approaches including CRISPR knockout, knock-in, overexpression, and CRISPR library screening to dissect gene function and signaling networks.
Description
The Gene Ontology term GO:0033280, response to vitamin D, defines any process that results in a change in state or activity of a cell or an organism as a result of a vitamin D stimulus. This includes changes in movement, secretion, enzyme production, and gene expression. Vitamin D is a secosteroid hormone that acts through the vitamin D receptor (VDR) to regulate a wide array of biological processes, from calcium homeostasis to immune modulation. Understanding this response is critical for researchers in endocrinology, immunology, and nutrition, as it underpins the mechanisms by which vitamin D influences health and disease. The biological effects of vitamin D are mediated by its active metabolite, 1,25-dihydroxyvitamin D, which binds to VDR and modulates transcription of target genes. This response is essential for maintaining mineral homeostasis, bone health, and immune function. Dysregulation of vitamin D signaling has been implicated in chronic liver diseases, respiratory infections, and muscle function. Therefore, dissecting the molecular players and regulatory networks of response to vitamin D is a key research objective. Recent advances in CRISPR gene editing and high-throughput screening have enabled systematic interrogation of genes involved in vitamin D response. By combining knockout, point mutation, knock-in, and overexpression models with functional genomics, researchers can uncover causal genes and pathways. This article provides a comprehensive overview of the ontology, mechanisms, key genes, disease links, and research methodologies for studying GO:0033280.
response to vitamin D At A Glance
| GO ID | GO:0033280 |
|---|---|
| GO term | response to vitamin D |
| Ontology | biological_process |
| Synonym | response to calciferol, response to cholecalciferol, response to ergocalciferol |
| Major function | Mediates cellular and systemic changes in response to vitamin D, including gene expression, calcium homeostasis, and immune modulation |
| Definition | Any process that results in a change in state or activity of a cell or an organism as a result of a vitamin D stimulus |
| Related GO terms | response to vitamin, response to steroid hormone, vitamin D metabolic process |
| Key regulator | Vitamin D receptor (VDR) and its heterodimer partner RXR |
| Physiological outcome | Regulation of calcium and phosphate homeostasis, bone mineralization, immune function, and cell differentiation |
What Is GO:0033280?
In our own words, GO:0033280 response to vitamin D refers to the collection of cellular and organismal processes triggered by exposure to vitamin D or its metabolites. It encompasses signal transduction, transcriptional regulation, and metabolic adjustments that allow a cell or organism to react to vitamin D. This term is a biological process and includes responses to calciferol, cholecalciferol, and ergocalciferol.
Why Is response to vitamin D Important in Cell Biology?
Response to vitamin D is critically important because vitamin D deficiency affects over a billion people worldwide and is associated with increased risk of respiratory infections, autoimmune diseases, chronic liver disease, and muscle weakness. Understanding the molecular mechanisms of this response can inform supplementation strategies, vaccine adjuvants, and therapeutic interventions targeting VDR signaling.
• Vitamin D supplementation reduces the risk of acute respiratory infections, especially in severely deficient individuals.
• The response to vitamin D is essential for calcium and phosphate homeostasis and bone health.
• VDR signaling modulates innate and adaptive immunity, influencing vaccine responses.
• Dysregulation of vitamin D response is linked to chronic liver diseases.
• Vitamin D affects muscle strength and physical performance in athletes.
• Both vitamin D2 and D3 elicit responses, but D3 is more effective at raising serum 25(OH)D.
• Genetic variation in vitamin D binding protein (GC) may influence 25(OH)D response to supplementation.
• The response to vitamin D involves rapid and sustained changes in gene expression, making it a model for nuclear receptor signaling.
• CRISPR screening can identify novel regulators of vitamin D response, offering therapeutic targets.
• Understanding dose-response relationships of vitamin D metabolites like PTH and FGF23 is clinically relevant.
What Happens During response to vitamin D?
Vitamin D uptake and metabolism
In simple terms: The body takes up vitamin D from food or makes it in the skin, then converts it into its active form.
Vitamin D (D2 or D3) is absorbed from the diet or synthesized in the skin upon UVB exposure. It is then hydroxylated in the liver to 25-hydroxyvitamin D [25(OH)D], the major circulating form, and further hydroxylated in the kidney to 1,25-dihydroxyvitamin D, the active hormone. This metabolic activation is a prerequisite for triggering the response to vitamin D.
VDR activation and heterodimerization
In simple terms: The active vitamin D binds to a receptor inside cells, which then pairs with another protein to control gene activity.
1,25-dihydroxyvitamin D binds to the vitamin D receptor (VDR), a nuclear receptor. Ligand-bound VDR heterodimerizes with the retinoid X receptor (RXR) and binds to vitamin D response elements (VDREs) in the DNA, thereby regulating transcription of target genes. This is the central molecular event in the response to vitamin D.
Transcriptional regulation of target genes
In simple terms: The activated receptor turns genes on or off, leading to changes in cell behavior.
VDR-RXR complexes recruit coactivators or corepressors to modulate the expression of genes involved in calcium transport (e.g., TRPV6, CALB1), bone remodeling (e.g., RANKL, OPG), immune function (e.g., cathelicidin), and cell cycle regulation. This transcriptional response underlies the diverse biological effects of vitamin D.
Non-genomic actions
In simple terms: Vitamin D can also trigger rapid cellular responses without directly changing gene expression.
In addition to genomic effects, vitamin D can induce rapid non-genomic responses via membrane-associated VDR or other receptors, leading to activation of signaling cascades such as MAPK and PKC. These rapid actions contribute to the overall response to vitamin D.
Feedback regulation and catabolism
In simple terms: The body adjusts vitamin D levels by breaking it down or reducing its production when levels are high.
The response to vitamin D is tightly regulated by feedback loops. 1,25-dihydroxyvitamin D induces CYP24A1, which catabolizes both 25(OH)D and 1,25-dihydroxyvitamin D, thereby limiting its own action. Additionally, parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) modulate vitamin D metabolism in response to calcium and phosphate status.
Key Genes Involved in GO:0033280 response to vitamin D
The following genes are central to the response to vitamin D, encompassing metabolism, receptor signaling, and downstream effectors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VDR | Nuclear receptor for 1,25-dihydroxyvitamin D; mediates transcriptional regulation | Central to all genomic vitamin D responses; target for knockout and knock-in studies |
| CYP27B1 | 1-alpha-hydroxylase; converts 25(OH)D to active 1,25-dihydroxyvitamin D | Determines local activation of vitamin D; knockout models show impaired response |
| CYP24A1 | 24-hydroxylase; inactivates vitamin D metabolites | Feedback regulator; overexpression reduces vitamin D response |
| GC | Vitamin D binding protein; transports vitamin D metabolites | Genetic variants may influence 25(OH)D levels and response to supplementation |
| RXRA | Retinoid X receptor alpha; heterodimer partner of VDR | Essential for VDR-mediated transcription; knockout impairs vitamin D signaling |
| TRPV6 | Calcium channel; mediates intestinal calcium absorption | VDR target gene; used as readout of vitamin D response |
| CALB1 | Calbindin-D9k; calcium-binding protein | VDR target; marker of vitamin D action in intestine and kidney |
| CAMP | Cathelicidin antimicrobial peptide | VDR target in innate immunity; links vitamin D to infection defense |
| RANKL (TNFSF11) | Cytokine involved in osteoclast differentiation | VDR target; regulates bone remodeling in response to vitamin D |
| OPG (TNFRSF11B) | Osteoprotegerin; decoy receptor for RANKL | Modulates bone metabolism; VDR target |
| PTH | Parathyroid hormone; regulates calcium and vitamin D metabolism | Feedback regulator; its suppression reflects vitamin D response |
| FGF23 | Fibroblast growth factor 23; regulates phosphate and vitamin D | Feedback regulator; dose-response to vitamin D analogs |
| KL (Klotho) | Co-receptor for FGF23 | Modulates FGF23 signaling and vitamin D metabolism |
| SLC34A1 | Sodium-phosphate cotransporter | Regulated by vitamin D and PTH; involved in phosphate homeostasis |
| CUBN | Cubilin; receptor for vitamin D binding protein complex | Mediates uptake of 25(OH)D in kidney |
| LRP2 | Megalin; endocytic receptor for vitamin D metabolites | Facilitates renal reabsorption of 25(OH)D |
| NR1H4 (FXR) | Nuclear receptor; crosstalk with VDR | Modulates vitamin D response in liver and intestine |
| STAT1 | Transcription factor; interacts with VDR signaling | Modulates immune responses to vitamin D |
How Is response to vitamin D Regulated?
The response to vitamin D is regulated at multiple levels. The availability of active hormone is controlled by CYP27B1 and CYP24A1, which are themselves regulated by PTH, FGF23, and 1,25-dihydroxyvitamin D. VDR activity is modulated by coactivators and corepressors, and by post-translational modifications. Additionally, the vitamin D binding protein (GC) influences the bioavailability of vitamin D metabolites. Feedback loops involving PTH and FGF23 maintain systemic calcium and phosphate homeostasis.
response to vitamin D and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| VDR | Vitamin D-resistant rickets, immune disorders | Knockout mice, patient-derived iPSCs with point mutations |
| CYP27B1 | Vitamin D-dependent rickets type I | Knockout cell lines, knock-in of patient mutations |
| CYP24A1 | Idiopathic infantile hypercalcemia | Overexpression and knockout models |
| GC | Vitamin D deficiency, liver disease | Knockout mice, human cohort studies with GC haplotypes |
| CAMP | Susceptibility to respiratory infections | Knockout and overexpression in airway epithelial cells |
Vitamin D deficiency and respiratory infections
Vitamin D deficiency is associated with increased susceptibility to acute respiratory infections. A meta-analysis of individual participant data showed that vitamin D supplementation reduces the risk of acute respiratory infections, particularly in individuals with severe deficiency. The response to vitamin D in immune cells involves induction of antimicrobial peptides such as cathelicidin, which enhances pathogen clearance.
Chronic liver diseases
Vitamin D and its binding protein play significant roles in chronic liver diseases. Patients with liver cirrhosis often have low 25(OH)D levels, and vitamin D deficiency correlates with disease severity and outcomes. The response to vitamin D in hepatic stellate cells and immune cells may influence fibrosis and inflammation.
Muscle function and performance
Vitamin D supplementation has been studied for its effects on muscle strength in athletes. A systematic review found that vitamin D supplementation may improve muscle strength, particularly in athletes with deficiency. The response to vitamin D in skeletal muscle involves VDR-mediated gene expression and rapid signaling pathways.
Chronic kidney disease and mineral bone disorder
In end-stage renal failure, the response to vitamin D analogs such as paricalcitol is impaired, and dose-response relationships of PTH and FGF23 are altered. These patients require careful monitoring of vitamin D metabolites to manage secondary hyperparathyroidism and bone disease.
From response to vitamin D-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does VDR mediate the transcriptional response to vitamin D? | VDR knockout cell lines (e.g., HEK293, U2OS) generated by CRISPR |
| How do point mutations in VDR affect ligand binding? | Knock-in of specific VDR mutations (e.g., R274L) using CRISPR |
| What is the effect of CYP24A1 overexpression on vitamin D response? | CYP24A1 overexpression cell lines |
| Can we identify novel regulators of vitamin D response? | Genome-wide CRISPR knockout library screening |
| How does the GC haplotype influence 25(OH)D response? | Knock-in of GC variants in hepatocyte-like cells |
| Does vitamin D induce cathelicidin in immune cells? | CAMP promoter-reporter knock-in in macrophages |
How to Study the response to vitamin D Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify VDR target genes and pathways |
| ChIP-seq | Genome-wide binding of VDR/RXR | Map VDREs and enhancers |
| CRISPR knockout screening | Gene essentiality or fitness in response to vitamin D | Discover novel regulators of vitamin D response |
| Proteomics | Protein abundance and modifications | Validate transcriptomic findings and identify non-genomic effects |
| Reporter assays | Transcriptional activity of VDREs | Test VDR variants and mutations |
| qPCR | Expression of specific target genes | Validate RNA-seq results and screen samples |
| Western blot | Protein levels of VDR and targets | Assess VDR stability and signaling |
| Immunofluorescence | Subcellular localization of VDR | Study VDR nuclear translocation |
Transcriptomic profiling (RNA-seq)
RNA sequencing allows comprehensive analysis of gene expression changes in response to vitamin D. By comparing treated and untreated cells, researchers can identify VDR target genes and pathways. This method is widely used to study the transcriptional response to vitamin D in various cell types.
Chromatin immunoprecipitation sequencing (ChIP-seq)
ChIP-seq for VDR and RXR can map genome-wide binding sites of the VDR-RXR complex upon vitamin D treatment. This reveals direct target genes and enhancer regions containing VDREs, providing mechanistic insights into the response to vitamin D.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes that modulate the response to vitamin D. For example, a screen for regulators of VDR activity or vitamin D-induced growth inhibition can uncover novel components of the pathway.
Mass spectrometry-based proteomics
Proteomic approaches can quantify changes in protein abundance and post-translational modifications in response to vitamin D. This complements transcriptomic data and reveals non-genomic effects.
How CRISPR Can Be Used to Study GO:0033280 response to vitamin D
Knockout
CRISPR knockout of VDR or metabolic enzymes (CYP27B1, CYP24A1) creates cell models to study the loss of response to vitamin D. These models are essential for dissecting the contribution of specific genes to vitamin D signaling and for identifying compensatory pathways.
Point Mutation
Introducing point mutations in VDR (e.g., those found in vitamin D-resistant rickets) via CRISPR allows precise analysis of ligand binding, DNA binding, and cofactor recruitment. Such models help correlate genotype with phenotype in the response to vitamin D.
Knock-in
Knock-in of tagged VDR (e.g., GFP or HA) enables live-cell imaging and chromatin immunoprecipitation. Knock-in of VDRE-driven reporter genes allows real-time monitoring of transcriptional response to vitamin D.
Overexpression
Overexpression of VDR or its target genes (e.g., CYP24A1) can amplify or dampen the response to vitamin D. These models are useful for studying dose-response relationships and for screening agonists and antagonists.
How EDITGENE Supports response to vitamin D Research
Researchers studying response to vitamin D-related genes often need to determine whether a candidate gene is causally involved in the cellular response to vitamin D or is merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for response to vitamin D research.
Frequently Asked Questions About response to vitamin D
What is GO:0033280 response to vitamin D?
GO:0033280 is a Gene Ontology biological process term that describes any process resulting in a change in state or activity of a cell or organism in response to a vitamin D stimulus, including gene expression, secretion, and enzyme production.
What genes are involved in response to vitamin D?
Key genes include VDR, CYP27B1, CYP24A1, GC, RXRA, and downstream targets such as TRPV6, CALB1, and CAMP.
How does vitamin D exert its effects?
Vitamin D is metabolized to 1,25-dihydroxyvitamin D, which binds to the vitamin D receptor (VDR), a nuclear receptor that heterodimerizes with RXR and regulates transcription of target genes.
What is the role of VDR in vitamin D response?
VDR is the primary mediator of genomic vitamin D responses. It binds vitamin D response elements (VDREs) and recruits coactivators or corepressors to modulate gene expression.
Can vitamin D supplementation prevent respiratory infections?
A meta-analysis of individual participant data found that vitamin D supplementation reduces the risk of acute respiratory infections, especially in individuals with severe deficiency.
What is the difference between vitamin D2 and D3 in raising 25(OH)D?
Both D2 and D3 raise serum 25(OH)D, but D3 is generally more effective at sustaining circulating levels, as shown in systematic reviews and meta-analyses.
How is response to vitamin D studied in the lab?
Common methods include RNA-seq, ChIP-seq, CRISPR knockout and knock-in models, reporter assays, and proteomics.
What diseases are linked to impaired vitamin D response?
Impaired vitamin D response is linked to chronic liver diseases, respiratory infections, muscle weakness, and chronic kidney disease.
What is the role of CYP24A1 in vitamin D response?
CYP24A1 is a 24-hydroxylase that inactivates vitamin D metabolites, providing negative feedback to limit the response to vitamin D.
How can CRISPR screening help study vitamin D response?
Genome-wide CRISPR screens can identify novel genes that regulate the response to vitamin D, offering potential therapeutic targets.
Conclusion
GO:0033280 response to vitamin D is a fundamental biological process with broad implications for human health, from immune defense to bone metabolism. The pathway is orchestrated by the vitamin D receptor and a network of metabolic enzymes and target genes. Understanding this response at the molecular level can inform nutritional guidelines and therapeutic strategies for vitamin D-related diseases. EDITGENE provides the CRISPR tools and services needed to dissect this pathway with precision and scale.
References
- 1. Martineau AR et al.. 2019. Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis.. Health Technol Assess 23(2):1-44 PMID: 30675873
- 2. Tripkovic L et al.. 2012. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis.. Am J Clin Nutr 95(6):1357-64 PMID: 22552031
- 3. Pop TL et al.. 2022. The Role of Vitamin D and Vitamin D Binding Protein in Chronic Liver Diseases.. Int J Mol Sci 23(18) PMID: 36142636
- 4. Chiang CM et al.. 2017. Effects of Vitamin D Supplementation on Muscle Strength in Athletes: A Systematic Review.. J Strength Cond Res 31(2):566-574 PMID: 27379960
- 5. van den Heuvel EG et al.. 2024. Comparison of the Effect of Daily Vitamin D2 and Vitamin D3 Supplementation on Serum 25-Hydroxyvitamin D Concentration (Total 25(OH)D, 25(OH)D2, and 25(OH)D3) and Importance of Body Mass Index: A Systematic Review and Meta-Analysis.. Adv Nutr 15(1):100133 PMID: 37865222
- 6. Simpson CA et al.. 2021. 25-OHD response to vitamin D supplementation in children: effect of dose but not GC haplotype.. Eur J Endocrinol 185(2):333-342 PMID: 34128826
- 7. Lang PO et al.. 2015. Can we translate vitamin D immunomodulating effect on innate and adaptive immunity to vaccine response?. Nutrients 7(3):2044-60 PMID: 25803545
- 8. Mussmaecher N et al.. 2026. Dose response of PTH and FGF23 to paricalcitol in patients with end-stage renal failure on chronic intermittent hemodialysis.. Clin Nephrol 105(3):160-170 PMID: 41378845
